270 related articles for article (PubMed ID: 9579567)
1. Iatrogenic risks of endometrial carcinoma after treatment for breast cancer in a large French case-control study. Fédération Nationale des Centres de Lutte Contre le Cancer (FNCLCC).
Mignotte H; Lasset C; Bonadona V; Lesur A; Luporsi E; Rodier JF; Cutuli B; Lasry S; Mauriac L; Granon C; Kerr C; Giard S; Hill C; de Lafontan B; de Gislain C; D'Anjou J; Fondrinier E; Lefeuvre C; Parache RM; Chauvin F
Int J Cancer; 1998 May; 76(3):325-30. PubMed ID: 9579567
[TBL] [Abstract][Full Text] [Related]
2. Risk and prognosis of endometrial cancer after tamoxifen for breast cancer. Comprehensive Cancer Centres' ALERT Group. Assessment of Liver and Endometrial cancer Risk following Tamoxifen.
Bergman L; Beelen ML; Gallee MP; Hollema H; Benraadt J; van Leeuwen FE
Lancet; 2000 Sep; 356(9233):881-7. PubMed ID: 11036892
[TBL] [Abstract][Full Text] [Related]
3. Endometrial cancer survival after breast cancer in relation to tamoxifen treatment: pooled results from three countries.
Jones ME; van Leeuwen FE; Hoogendoorn WE; Mourits MJ; Hollema H; van Boven H; Press MF; Bernstein L; Swerdlow AJ
Breast Cancer Res; 2012 Jun; 14(3):R91. PubMed ID: 22691381
[TBL] [Abstract][Full Text] [Related]
4. Endometrial cancer following breast cancer: Effect of tamoxifen and castration by radiotherapy.
Sasco AJ; Chaplain G; Amoros E; Saez S
Epidemiology; 1996 Jan; 7(1):9-13. PubMed ID: 8664408
[TBL] [Abstract][Full Text] [Related]
5. A retrospective study of tamoxifen and endometrial cancer in breast cancer patients.
Robinson DC; Bloss JD; Schiano MA
Gynecol Oncol; 1995 Nov; 59(2):186-90. PubMed ID: 7590470
[TBL] [Abstract][Full Text] [Related]
6. Endometrial carcinoma following treatment for breast carcinoma in a Nigerian female. A case report and review of the literature.
Abudu EK; Musa O; Adefuye PO; Abdul Kareem FB; Agboola AO; Banjo AA
Niger Postgrad Med J; 2007 Dec; 14(4):355-7. PubMed ID: 18163149
[TBL] [Abstract][Full Text] [Related]
7. Detection of endometrial cancer in asymptomatic postmenopausal breast cancer patient treated with tamoxifen: a case report.
Sinawat S; Chiyabutra T; Kleabkaew P
J Med Assoc Thai; 2001 Jul; 84(7):1033-6. PubMed ID: 11759963
[TBL] [Abstract][Full Text] [Related]
8. The incidence of subsequent endometrial carcinoma with tamoxifen use in patients with primary breast carcinoma.
Katase K; Sugiyama Y; Hasumi K; Yoshimoto M; Kasumi F
Cancer; 1998 May; 82(9):1698-703. PubMed ID: 9576291
[TBL] [Abstract][Full Text] [Related]
9. Tamoxifen adjuvant treatment duration in early breast cancer: initial results of a randomized study comparing short-term treatment with long-term treatment. Fédération Nationale des Centres de Lutte Contre le Cancer Breast Group.
Delozier T; Spielmann M; Macé-Lesec'h J; Janvier M; Hill C; Asselain B; Julien JP; Weber B; Mauriac L; Petit JC; Kerbrat P; Malhaire JP; Vennin P; Leduc B; Namer M
J Clin Oncol; 2000 Oct; 18(20):3507-12. PubMed ID: 11032592
[TBL] [Abstract][Full Text] [Related]
10. Tamoxifen treatment for breast cancer and risk of endometrial cancer: a case-control study.
Swerdlow AJ; Jones ME;
J Natl Cancer Inst; 2005 Mar; 97(5):375-84. PubMed ID: 15741574
[TBL] [Abstract][Full Text] [Related]
11. Tamoxifen therapy for breast cancer and endometrial cancer risk.
Bernstein L; Deapen D; Cerhan JR; Schwartz SM; Liff J; McGann-Maloney E; Perlman JA; Ford L
J Natl Cancer Inst; 1999 Oct; 91(19):1654-62. PubMed ID: 10511593
[TBL] [Abstract][Full Text] [Related]
12. Surveillance for uterine abnormalities in tamoxifen-treated breast carcinoma survivors: a community based study.
Althuis MD; Sexton M; Langenberg P; Bush TL; Tkaczuk K; Magaziner J; Khoo L
Cancer; 2000 Aug; 89(4):800-10. PubMed ID: 10951343
[TBL] [Abstract][Full Text] [Related]
13. Population-based study of tamoxifen therapy and subsequent ovarian, endometrial, and breast cancers.
Cook LS; Weiss NS; Schwartz SM; White E; McKnight B; Moore DE; Daling JR
J Natl Cancer Inst; 1995 Sep; 87(18):1359-64. PubMed ID: 7658496
[TBL] [Abstract][Full Text] [Related]
14. Risk of endometrial cancer after tamoxifen treatment of breast cancer.
van Leeuwen FE; Benraadt J; Coebergh JW; Kiemeney LA; Gimbrère CH; Otter R; Schouten LJ; Damhuis RA; Bontenbal M; Diepenhorst FW
Lancet; 1994 Feb; 343(8895):448-52. PubMed ID: 7905955
[TBL] [Abstract][Full Text] [Related]
15. Uterine side effects of tamoxifen: a need for systematic pretreatment screening.
Berlière M; Charles A; Galant C; Donnez J
Obstet Gynecol; 1998 Jan; 91(1):40-4. PubMed ID: 9464718
[TBL] [Abstract][Full Text] [Related]
16. The potential oncogenic effect of tamoxifen on the endometrium.
Berlière M; Galant C; Donnez J
Hum Reprod; 1999 May; 14(5):1381-3. PubMed ID: 10325299
[TBL] [Abstract][Full Text] [Related]
17. Second cancers after adjuvant tamoxifen therapy for breast cancer in Japan.
Matsuyama Y; Tominaga T; Nomura Y; Koyama H; Kimura M; Sano M; Miura S; Takashima S; Mitsuyama S; Ueo H; Ohashi Y
Ann Oncol; 2000 Dec; 11(12):1537-43. PubMed ID: 11205460
[TBL] [Abstract][Full Text] [Related]
18. First results from the International Breast Cancer Intervention Study (IBIS-I): a randomised prevention trial.
Cuzick J; Forbes J; Edwards R; Baum M; Cawthorn S; Coates A; Hamed A; Howell A; Powles T;
Lancet; 2002 Sep; 360(9336):817-24. PubMed ID: 12243915
[TBL] [Abstract][Full Text] [Related]
19. [Endometrial cancer and tamoxifen. Discussion apropos of a series of cases].
Sasco AJ; Ah-Song R; Gendre I; Zlatoff P; Bobin JY; Hallonet P; Leduc B
Bull Cancer; 1997 Jan; 84(1):51-60. PubMed ID: 9180860
[TBL] [Abstract][Full Text] [Related]
20. Utilization of gynecologic services in women with breast cancer receiving hormonal therapy.
Wright JD; Desai VB; Chen L; Burke WM; Tergas AI; Hou JY; Accordino M; Ananth CV; Neugut AI; Hershman DL
Am J Obstet Gynecol; 2017 Jul; 217(1):59.e1-59.e12. PubMed ID: 28341383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
